Ameliorative effect of borneol, a natural bycyclic monoterpene against hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic Wistar rats

Biomedicine and Pharmacotherapy

Volumn 96, Issue , 2017, Pages 336-347

  Kodikonda, Madhuri ^a   Naik, Prakash Ramachandra ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Antioxidant; Beta cell; Hypoglycemic; Hypolipidemic; Insulin; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BORNEOL; CATALASE; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; GLYCOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UREA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIDIABETIC AGENT; BORNANE DERIVATIVE; ISOBORNEOL; STREPTOZOCIN; TERPENE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL COUNT; CELLS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HOMEOSTASIS MODEL ASSESSMENT; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PHYSIOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; BORNANES; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; MALE; MONOTERPENES; OXIDATIVE STRESS; RATS; RATS, WISTAR; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 85030849960     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.09.122     Document Type: Article

References (86)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34:1 (2011), 62–69.
2. American Diabetes Association (ADA), Diagnosis and classification of diabetes mellitus. Diabetes Care 33:Suppl. 1 (2012), S62–S69.
3. Li, W.L., Zheng, H.C., Bukuru, J., De Kimpe, N., Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 92 (2004), 1–21.
4. Singab, A.N., Youssef, F.S., Ashour, M.L., Medicinal plants with potential antidiabetic activity and their assessment. Med. Aromat. Plants 3 (2014), 1–12.
5. Puranik, N., Kammar, K.F., Devi, S., Anti-diabetic activity of Tinospora cordifolia (Willd.) in streptozotocin diabetic rats; does it act like sulfonylureas?. Turk. J. Med. Sci. 40 (2010), 265–270.
6. Meenakshi, P., Bhuvaneshwari, R., Rathi, M.A., Thirumoorthi, L., Guravaiah, D.C., Jiji, M.J., Gopalakrishnan, V.K., Antidiabetic activity of ethanolic extract of Zaleya decandra in alloxan-induced diabetic rats. Appl. Biochem. Biotechnol. 162 (2010), 1153–1159.
7. Moller, D.E., New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414 (2001), 821–827.
8. Goodarzi, M.O., Bryer-Ash, M., Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes. Metab. 7 (2005), 654–665.
9. Aksoy, N., Vural, H., Sabuncu, T., Aksoy, S., Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats. Cell Biochem. Funct. 21 (2003), 121–125.
10. Kaya-Dagistanli, F., Ozturk, M., The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administered rats. Acta Histochem. 115 (2013), 577–586.
11. Ashcroft, F.M., Gribble, F.M., ATP-sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia 42 (1999), 903–919.
12. Szkudelski, T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50 (2001), 536–546.
13. Sandler, S., Swenne, I., Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro. Diabetologia 25 (1983), 444–447.
14. Heller, B., Burkle, A., Radons, J., Fengler, E., Jalowy, A., Muller, M., Burkart, V., Kolb, H., Analysis of oxygen radical toxicity in pancreatic islets at the single cell level. Biol. Chem. Hoppe. Seyler 375 (1994), 597–602.
15. Bedoya, F.J., Solano, F., Lucas, M., N-Monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia 52 (1996), 344–347.
16. Ohkuwa, T., Sato, Y., Naoi, M., Hydroxyl radical formation in diabetic rat induced by streptozotocin. Life Sci. 56 (1995), 1789–1798.
17. Tiedge, M., Lortz, S., Drinkgern, J., Lenzen, S., Relation between antioxidant enzyme gene expression and antioxidative defense system status of insulin producing cells. Diabetes 46 (1997), 1733–1742.
18. Nukatsuka, M., Yoshimura, Y., Nishida, M., Kawada, J., Importance of the concentration of ATP in rat pancreatic beta cells in the mechanism of streptozotocin-induced cytotoxicity. J. Endocrinol. 127 (1990), 161–165.
19. Tabanca, N., Kirimer, N., Demirci, B., Demirci, F., Baser, K.H.C., Composition and Antimicrobial Activity of the Essential Oils of Micromeria cristata subsp. phrygia and the Enantiomeric Distribution of Borneol. J. Agric. Food Chem. 49 (2001), 4300–4303.
20. Candan, F., Unla, M., Tepe, B., Daferera, D., Polissiou, M., Samen, A., Akpulat, H.A., Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae). J. Ethnopharmacol. 87 (2003), 215–220.
21. Su, J., Chen, J., Liao, S., Li, L., Zhu, L., Chen, L., Composition and biological activities of the essential oil extracted from a novel plant of Cinnamomum camphora Chvar. Borneol. J. Med. Plants Res. 6 (2012), 3487–3494.
22. Wenqiang, G., Shufen, L., Ruixiang, Y., Yanfeng, H., Comparison of composition and antifungal activity of Artemisia argyi Levl. et Vant inflorescence essential oil extracted by hydrodistillation and supercritical carbon dioxide. Nat. Prod. Res. 20 (2006), 992–998.
23. Tambe, R., Jain, P., Patil, S., Ghumatkar, P., Sathaye, S., Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice. Naunyn-Schmiedebergs Arch. Pharmacol. 389 (2016), 467–475S.
24. Kumar, M.S., Kumar, S., Raja, B., Antihypertensive and antioxidant potential of borneol-A natural terpene in L-NAME-induced hypertensive rats. Int. J. Pharm. Biol. Arch. 1 (2010), 271–279.
25. Li, Y.H., Sun, X.P., Zhang, Y.Q., Wang, N.S., The antithrombotic effect of borneol related to its anticoagulant property. Am. J. Chin. Med. 36 (2008), 719–727.
26. Juhás, Cikos, S., Czikková, S., Veselá, J., II'ková, G., Hájek, T., Domaracká, K., Domaracky, M., Bujnáková, D., Rehák, P., Koppel, J., Effects of borneol and thymoquinone on TNBS-induced colitis in mice. Folia Biol. (Praha) 54 (2008), 1–7.
27. Almeida, J.R., Souza, G.R., Silva, J.C., Saraiva, S.R., Júnior, R.G., Quintans Jde, S., Barreto Rde, S., Bonjardim, L.R., Cavalcanti, S.C., Quintans, L.J. Jr, Borneol, a bicyclic monoterpene alcohol, reduces nociceptive behavior and inflammatory response in mice. Sci. World J., 2013, 10.1155/2013/808460.
28. Silva-Filho, J.C., Oliveira, N.N., Arcanjo, D.D., Quintans-Junior, L.J., Cavalcanti, S.C., Santos, M.R., Oliveira Rde, C., Oliveira, A.P., Investigation of mechanisms involved in (−)-Borneol-induced vasorelaxant response on rat thoracic aorta. Basic Clin. Pharmacol. Toxicol. 110 (2011), 171–177.
29. Liu, R., Zhang, L., Lan, X., Li, L., Zhang, T.T., Sun, J.H., Du, G.H., Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κB signaling pathway. Neuroscience 176 (2011), 408–419.
30. Li, F., Feng, J., Cheng, Q., Zhu, W., Jin, Y., Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats. Int. J. Pharm. 328 (2007), 161–167.
31. Dai, J.P., Chen, J., Bei, Y.F., Han, B.X., Wang, S., Influence of borneol on primary mice oral fibroblasts: a penetration enhancer may be used in oral submucous fibrosis. J. Oral Pathol. Med. 38 (2009), 276–281.
32. Horváthová, E., Kozics, K., Srančíková, A., Hunáková, L., Gálová, E., Ševčovičová, A., Slameňová, D., Borneol administration protects primary rat hepatocytes against exogenous oxidative DNA damage. Mutagenesis 27 (2012), 581–588.
33. Umasankar, K., Ramya, D.R., Nambikkairaj, B., Antidiabetic and antidyslipidemic nature of carvacrol, a monoterpenic phenol studied in high-fat-fed and low-dose streptozotocin-induced experimental diabetic rats. J. Pharm. Res. 9 (2015), 484–490.
34. Muruganathan, U., Srinivasan, S., Beneficial effect of carvone, a dietary monoterpene ameliorates hyperglycemia by regulating the key enzymes activities of carbohydrate metabolism in streptozotocin-induced diabetic rats. Biomed. Pharmacother. 84 (2016), 1558–1567.
35. Murali, R., Saravanan, R., Antidiabetic effect of D-limonene, a monoterpene in streptozotocin-induced diabetic rats. Biomed. Prev. Nutr. 2 (2012), 269–275.
36. Srinivasan, S., Muruganathan, U., Antidiabetic efficacy of citronellol, a citrus monoterpene by ameliorating the hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 25 (2016), 38–46.
37. Abdelmeguid, N.E., Fakhoury, R., Kamal, S.M., Al Wafai, R.J., Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. J. Diabetes 2 (2010), 256–266.
38. Al-Sa'aidi, J.A.A., Kareem, H.M.A., Al-Tameemi, W.T.M., Antihyperglycemic effects of thymoquinone in diabetic rats. Bas. J. Vet. Res. 13 (2014), 180–192.
39. Alkhateeb, H.H., Thujone improves glucose homeostasis in streptozotocin-induced diabetic rats through activation of Akt/glycogen synthase kinase-3β signaling pathway. J. Exp. Integr. Med. 5 (2015), 30–35.
40. Samarghandian, S., Borji, A., Delkhosh, M.B., Samini, F., Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic Rats. J. Pharm. Pharm. Sci. 16 (2013), 352–362.
41. Babukumar, S., Vinothkumar, V., Sankaranarayanan, C., Srinivasan, S., Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharm. Biol. 55 (2017), 1442–1449.
42. Ayyasamy, R., Leelavinothan, P., Myrtenal alleviates hyperglycaemia, hyperlipidaemia and improves pancreatic insulin level in STZ-induced diabetic rats. Pharm. Biol. 54 (2016), 2521–2527.
43. Muruganathan, U., Srinivasan, S., Vinothkumar, V., Antidiabetogenic efficiency of menthol, improves glucose homeostasis and attenuates pancreatic β-cell apoptosis in streptozotocin-nicotinamide induced experimental rats through ameliorating glucose metabolic enzymes. Biomed. Pharmacother. 92 (2017), 229–239.
44. Friedwald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of LDL-C in plasma without the use of the preparative ultracentrifuge. Clin. Chem. 18 (1972), 449–502.
45. Malspina, J.P., Bussiere, H., Clave, G.L., The total cholesterol/HDL cholesterol ratio: a suitable atherogenic index. Atherosclerosis, 40, 1981, 373.
46. Van Der Vies, J., Two methods for the determination of glycogen in liver. Biochem. J. 57 (1954), 410–416.
47. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
48. Marklund, S., Marklund, G., Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47 (1974), 469–473.
49. Sinha, A.K., Colorimetric assay of catalase. Anal. Biochem. 47 (1972), 389–394.
50. Ellman, G.L., Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959), 70–77.
51. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxidation on animal tissue by thiobarbituric acid reaction. Anal. Biochem., 18, 1979, 351358.
52. Chandavar, V.R., Naik, P.R., Variation in plasma glucose and pancreatic β-cells in the turtle, Lissemys punctata (Order, Chelonia, Family, Trionychidae). Acta Zool. 85 (2004), 113–118.
53. Schein, P.S., Cooney, D.A., McMenamin, M.G., Anderson, T., Streptozotocin diabetes—further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver. Biochem. Pharmacol. 22 (1973), 2625–2631.
54. Ding, Y., Zhang, Z., Dai, X., Jiang, Y., Bao, L., Li, Y., Li, Y., Grape seed proanthocyanidins ameliorate pancreatic beta-cell dysfunction and death in low-dose streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats partially by regulating endoplasmic reticulum stress. Nutr. Metab. (Lond.), 10, 2013, 51, 10.1186/1743-7075-10-51.
55. Giribabu, N., Kumar, K.E., Rekha, S.S., Muniandy, S., Salleh, N., Chlorophytum borivilianum root extract maintains near normal blood glucose, insulin and lipid profile levels and prevents oxidative stress in the pancreas of streptozotocin-induced adult male diabetic rats. Int. J. Med. Sci. 11 (2014), 1172–1184.
56. Jain, D., Somani, R., Gilhotra, R., Silibinin ameliorates hyperglycaemia, hyperlipidemia and prevent oxidative stress in streptozotocin induced diabetes in Sprague Dawley rats. Int. J. Pharm. Res. Appl. Sci. 5 (2016), 136–144.
57. Lyons, T.J., Basu, A., Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl. Res. 159 (2012), 303–312.
58. Saleh, A.A., Effect of taurine and/or ginseng and their mixture on lipid profile and some parameters indicative of myocardial status in streptozotocin-diabetic rats. J. Basic Appl. Zool. 65 (2012), 267–273.
59. Nain, P., Saini, V., Sharma, S., Nain, J., Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J. Ethnopharmacol. 142 (2012), 65–71.
60. Moore, C.J., Shao, C.H., Nagai, R., Kutty, S., Singh, J., Bidasee, K.R., Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco (endo) plasmic reticulum Ca2?-ATPase (SERCA2) in diabetes. Mol. Cell. Biochem. 376 (2013), 121–135.
61. Kalyani, R.R., Corriere, M., Ferrucci, L., Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 14 (2014), 70034–70038.
62. Whitton, P.D., Hems, D.A., Glycogen synthesis in the perfused liver of streptozotocin diabetic rats. Biochem. J. 150 (1975), 153–165.
63. Eliza, J., Daisy, P., Ignacimuthu, S., Duraipandiyan, V., Normo-glycemic and hypolipidemic effect of costunolide isolated from Costus speciosus (Koen ex. Retz.) Sm. in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 179 (2009), 329–334.
64. Begum, K., Rajini, P.S., Augmentation of hepatic and renal oxidative stress and disrupted glucose homeostasis by monocrotophos in streptozotocin-induced diabetic rats. Chem. Biol. Interact. 193 (2011), 240–245.
65. Kojima, N., Slaughter, T.N., Paige, A., Kato, S., Roman, R.J., Williams, J.M., Comparison of the development diabetic induced renal disease in strains of Goto-Kakizaki rats. J. Diabetes Metab. 9 (2013), 1–12.
66. Vijayaraghavan, K., Iyyam Pillai, S., Subramanian, S.P., Design, synthesis and characterization of zinc-3 hydroxy flavone, a novel zinc metallo complex for the treatment of experimental diabetes in rats. Eur. J. Pharmacol. 680 (2012), 122–129.
67. Hwang, H.J., Kim, S.W., Lim, J.M., Joo, J.H., Kim, H.O., Kim, H.M., Yun, J.W., Hypoglycemic effect of crude epoxypolysaccharides produced by a medicinal mushroom Phellinus baumii in Streptozotocin induced diabetic rats. Life Sci. 76 (2005), 3069–3080.
68. El-Demerdash, F.M., Yousef, M.I., AbouEl-Naga, N.I., Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 43 (2005), 57–63.
69. Bray, T.M., Dietary antioxidants and assessment of oxidative stress. Nutrition 16 (2000), 578–580.
70. Kim, H., Jeong, D., Jung, H., Yokozawa, T., Choi, J., Hypolipidemic effects of sophora flavescens and its constituents in poloxamer induced hyperlipidemic and cholesterol-fed rats. Biol. Pharm. Bull. 31 (2008), 73–78.
71. Pushparaj, P., Tan, C.H., Tan, B.K.H., Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rat. J. Ethnopharmacol. 72 (2000), 69–76.
72. Katan, M.B., The response of lipoproteins to dietary fat and cholesterol in lean and obese persons. Curr. Cardiol. Rep. 8 (2006), 446–451.
73. Farmer, J.A., Torre-Amione, G., Atherosclerosis and inflammation. Curr. Atheroscler. Rep. 4 (2000), 92–98.
74. Meydani, M., Vitamin E and atherosclerosis: beyond prevention of LDL oxidation. J. Nutr. 131 (2001), 366S–368S.
75. Bandeali, S., Farmer, J., High-density lipoprotein and atherosclerosis the role of antioxidant activity. Curr. Atheroscler. Rep. 14 (2012), 101–107.
76. Savel, J., Lafitte, M., Pucheu, Y., Pradeau, V., Very low levels of HDL cholesterol and atherosclerosis, a variable relationship-a review of LCAT deficiency. Vasc. Health Risk Manag. 8 (2012), 357–361.
77. Kripa, K., Vijayalakshmi, N.R., Helen, A., Methanolic extract of costus igneus (N.E.Br.) alleviates dyslipidemia in diabetic rats. Asian J. Pharm. Clin. Res. 4 (2011), 154–157.
78. Onunogbo, C., Ohaeri, O.C., Eleazu, C.O., Eleazu, K.C., Chemical composition of mistletoe extract (Loranthus micranthus) and its effect on the protein, lipid metabolism and the antioxidant status of alloxan induced diabetic rats. J. Med. Res. 1 (2012), 57–63.
79. West, C., Radicals and oxidative stress in diabetes. Diabetes Med. 17 (2000), 171–180.
80. Matough, F.A., Budin, S.B., Hamid, Z.A., Alwahaibi, N., Mohamed, J., The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ. Med. J. 12 (2012), 5–18.
81. Sellamuthu, P.S., Arulselvan, P., Muniappan, B.P., Fakurazi, S., Kandasamy, M., Mangiferin from Salacia chinensis prevents oxidative stress and protects pancreatic β-cells in streptozotocin-induced diabetic rats. J. Med. Food 16 (2013), 719–727.
82. Maria-Lusia Lazo-de-la-Vega-Monroy, Cristina Fernandez-Mejia, Oxidative Stress and Chronic Degenerative Diseases—A Role for Antioxidants, in: Jose A. Morales-Gonzalez (Ed.), ISBN 978-953-51-1123-8, May 22, 2013 under CC BY 3.0 licence, DOI: 10.5772/51788.
83. Butterfield, D.A., Koppal, T., Howard, B., Subramaniam, R., Hall, N., Hensley, K., Yatin, S., Allen, K., Aksenov, M., Aksenova, M., Carney, J., Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E. Ann. N. Y. Acad. Sci. 854 (1998), 448–462.
84. Oxidized LDL and atherogenesis. Ann. N. Y. Acad. Sci. 874 (1999), 134–137.
85. Rajasekaran, M., Kalaichelvan, S., Antioxidative role of Costus pictus D.DON in hyperglycemic rats administered with alloxon. J. Pharm. Sci. Res. 6 (2014), 24–28.
86. Ramesh, B., Pugalendi, K.V., Impact of umbelliferone (7-hydroxycoumarin) on hepatic marker enzymes in streptozotocin diabetic rats. Ind. J. Pharmacol. 38 (2006), 209–221.